Physician profile
Scott D Perry
NPI 1780840751
$8,307.41
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,799 · 2020: $16.33 · 2021: $811 · 2022: $158 · 2023: $38.26 · 2024: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocodex, INC. | $7,104.42 | 2019-2024 | |
| Cycle Pharmaceuticals INC | $565.00 | 2021 | |
| Neurelis, INC. | $340.99 | 2021-2024 | Valtoco |
| Greenwich Biosciences, INC. | $125.79 | 2019 | |
| Mindray Ds USA, INC. | $41.22 | 2021 | |
| Ucb, INC. | $38.26 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.73 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $24.34 | 2019 | |
| Clarus Therapeutics INC. | $18.96 | 2021 | |
| Gilead Sciences, INC. | $15.70 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.